[ Price : $8.95]
FDA updates FAQs on submitting adverse events reports for medical devices marketed under emergency use authorizations.[ Price : $8.95]
CDRH executives say they encourage and will consider innovative proposals from Covid-19 test developers.[ Price : $8.95]
FDA warns Nutritional Supplements Corp. that it is marketing unapproved and misbranded new drugs.[ Price : $8.95]
An FDA safety alert warns patients and health care providers about the risk of injury that may happen to patients if the cold-ther...[ Price : $8.95]
FDA clears a Roche 510(k) for the cobas BKV Test and its use on the cobas 6800 and 8800 Systems.[ Price : $8.95]
Researchers say that teaching hospitals that receive non-research payments from drug companies should guard against institutional ...[ Price : $8.95]
FDA approves an early feasibility study for Medtronics Intrepid valve replacement system in patients with severe tricuspid regurgi...[ Price : $8.95]
FDA warns Timurs (East Java, Indonesias) PT MegaSurya Mas drug manufacturing facility about CGMP violations in its production of f...